484 F.Supp.2d 289 (E.D.Pa. 2007), Civ. A. 06-1111, Sykes v. Glaxo-SmithKline
Linked as:
Extract
484 F.Supp.2d 289 (E.D.Pa. 2007), Civ. A. 06-1111, Sykes v. Glaxo-SmithKline
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Requirements on content and format of labeling for human prescription drug and biological products
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products described in section 201.56(b)(1)
- Code of Federal Regulations - Definitions
- Code of Federal Regulations - Changes to an approved application
- Code of Federal Regulations - Labeling, general requirements